Skip to main content
2026 ASCRS Annual Scientific Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
CME
CME
Invitation/Ticketed Event
Invitation/Ticketed Event
Invited Lectureship
Invited Lectureship
Award Recipient
Award Recipient
Live Streamed Session
Live Streamed Session
Nurses Contact Hours
Nurses Contact Hours
Self-Assessment
Self-Assessment
Live Q&A and Polling
Live Q&A and Polling
Social
Social
Industry
Industry

Session:: Best of Diseases of the Colon & Rectum

Immunotherapy Alone for Patients with Locally Advanced and Resectable Metastatic Colorectal Cancer of dMMR/MSI-H Status

Sunday, May 10, 2026
2:27 PM - 2:35 PM ET

    Faculty(s)

  • Aiwen Wu, MD, PhD

    Chief, GI Cancer Center, Unit III
    Peking University Cancer Hospital
    Peking University Cancer Hospital & Institute
    Beijing, Beijing, China (People's Republic)

    All disclosed relationships have been reviewed and managed prior to the start of this activity. Any relevant relationships will be listed below. This individual has no financial relationships to disclose

1.Preoperative single-agent PD-1 blockade immunotherapy as conversion strategy in patients with initially surgical resected
difficult dMMR/MSI-H colorectal cancer.2.Nonoperative Management of MSI-H or POLE-mt colorecal cancer